not to to get ahead of ourselves but in my mind todays circa 100m market cap should be closer to 200-400m if we didn't have such a habit of over promising on deals and if we had more cash. ie todays price isn't the right starting point for valuation.
I think fda approval and a deal will mean we re rate and I agree paro hopefully funds. deals plural mean I hope we sit around the 2 buck range for a while and even pre revenue as we progress to the end of the trial I don't think It is impossible we are 3-4-5 bucks. to your point PE in year 1-3 isn't so relevant, it's about is the drug getting sales traction and is it potentially a blockbuster.
at this point it's just a dream. I'm focused as I believe PAR is on fda / funding. let's cross that bridge first !
- Forums
- ASX - By Stock
- Sharewise Presentation 22/7/24
not to to get ahead of ourselves but in my mind todays circa...
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.5¢ |
Change
0.020(8.51%) |
Mkt cap ! $89.19M |
Open | High | Low | Value | Volume |
23.5¢ | 25.5¢ | 23.5¢ | $161.2K | 660.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 77422 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 15109 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 72422 | 0.250 |
3 | 402284 | 0.240 |
3 | 49455 | 0.235 |
8 | 216656 | 0.230 |
4 | 57500 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 15109 | 1 |
0.260 | 58362 | 1 |
0.270 | 20000 | 2 |
0.275 | 13636 | 2 |
0.280 | 223933 | 8 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online